Skip to content

The effect of an anesthetic combination drug containing Propofol-Remifentanil-Daxmedetomidine on blood pressure and heart rate and postoperative complications in spine and spinal cord surgery.

Comparison the effect of combination of Propofol-Remifentanil-Dexmedetomidine on hemodynamic parameters and postoperative complications in spine and spinal cord surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101630327N1
Enrollment
60
Registered
2016-11-30
Start date
2016-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

effect of drug. Unspecified adverse effect of drug or medicament

Interventions

Intervention 1: 15 minutes before time of induction, Daxmedetomidine 0.6mic / kg / h and remifentanil 1mic/Kg/min are infused, at the time of induction Propofol 1-2.5 mg/Kg and neuromuscular blocking
Prevention
15 minutes before time of induction, Daxmedetomidine 0.6mic / kg / h and remifentanil 1mic/Kg/min are infused, at the time of induction Propofol 1-2.5 mg/Kg and neuromuscular blocking drug (Cisatracur
15 minutes before time of induction, Remifentanil 1mic/Kg/min is infused, at the time of induction Propofol 1-2.5 mg/Kg and neuromuscular blocking drug (Cisatracurium) 0.15 mg/Kg are injected and pati

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients undergoing spine surgery and spinal referring to Imam Reza Kermanshah American Society of Anesthesiologists class (I-II). Exclusion criteria: patients with a history of severe systemic disease; body mass index greater than 30; patients with a history of high blood pressure (Blood Pressure greater than 140/90); severe respiratory diseases does not control; symptomatic heart disease; diabetic patients; consumers beta-blocker drugs; drug-addicted patients; patients with more than one laryngoscopy; the extreme sensitivity to drugs personality disorder; patients with more than 750 cc of blood during surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood Pressure. Timepoint: 15 minutes before induction, intubation time, two minutes afte intubation, time of change position, and two minutes after the change of position, intraoperative period in minutes of 15,30,45,90, time of repositioning, two minutes after switching position. and before extubation, two, thirty and sixty minutes after extubation. Method of measurement: in mmHg using mercuric manometer.;Heart Rate. Timepoint: 15 minutes before induction, intubation time, two minutes afte intubation, time of change position, and two minutes after the change of position, intraoperative period in minutes of 15,30,45,90, time of repositioning, two minutes after switching position. and before extubation, two, thirty and sixty minutes after extubation. Method of measurement: number of heart rate in one minute.

Secondary

MeasureTime frame
Shivering. Timepoint: Postoperative. Method of measurement: Standard questionnaire.;Nausea. Timepoint: Postoperative. Method of measurement: VAS.;Vomiting. Timepoint: Postoperative. Method of measurement: VAS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Javad Moradi

Kermanshah University of Medical Sciences

m_javad1550@yahoo.com+98 83 3427 6308

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026